Singleton Mark Leonard bought BVS
March 15, 2024 · Form 4 insider transaction
Singleton Mark Leonard bought 181,980 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
181,980
Price
$0.00
Total value
N/A
InsiderSingleton Mark Leonard
Role—
CompanyBioventus Inc. (BVS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 15, 2024
Filing dateMarch 22, 2024
Shares owned after181,980
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.